Wird geladen...
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
PURPOSE OF REVIEW: Rituximab-based chemoimmunotherapy has resulted in a marked improvement in the survival of diffuse large B cell lymphoma (DLBCL). We reflect upon the history front-line (1L) therapy and highlight advances in management. RECENT FINDINGS: Since the introduction of R-CHOP, the majori...
Gespeichert in:
| Veröffentlicht in: | Curr Hematol Malig Rep |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer US
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6647877/ https://ncbi.nlm.nih.gov/pubmed/31254155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-019-00518-8 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|